Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blue Belt Technologies, Inc.

http://www.bluebelttech.com/

Latest From Blue Belt Technologies, Inc.

Activ Surgical’s Platform Technology Strives To Be The ‘Waze’ Intra-Operative Navigation System For Surgeons

Activ Surgical’s CEO Todd Usen sat down with Medtech Insight to discuss the company’s product portfolio – ActivSight, an imaging module technology and ActivInsights, which uses artificial intelligence and machine learning to produce further clinical insights based on surgical data.

Innovation Artificial Intelligence

Role Of Digital Surgery Will Continue To Grow Despite Cost Constraints

Hospitals’ budgets for capital equipment have been strained during the pandemic, but they will continue to invest in digital surgery and robotics because the technologies offer value to patients, according to executives at The Virtual MedTech Conference.

Coronavirus COVID-19 Robotic Surgery

Expert Panel On Surgical Robotics Expects Autonomous Systems To Democratize Surgery

Autonomous robotic systems that enhance the skillset of surgeons face a gradual evolution, the experts agreed.

Robotic Surgery Artificial Intelligence

AAOS 2019: OSSO VR Develops VR Training Tool For Smith & Nephew's NAVIO Robot, And More On Orthorobotics

Osso VR partnered with Smith & Nephew to develop a VR training tool that will be showcased at this year's American Association of Orthopedic Surgeons' (AAOS) conference, taking place in Las Vegas from March 12-16. Orthopedic robotic systems continue to draw high interest from surgeons. The recent US FDA clearance of Zimmer Biomet's ROSA total knee replacement system will add competition to the current market dominated by Stryker's MAKO and Smith & Nephew's NAVIO.

Commercial Deals
See All

Company Information

UsernamePublicRestriction

Register